LONDON – The search for therapies that aim to harness the body's immune system to kill tumors, and for new vaccines that are more effective and long-lasting than those currently available, will be aided by the discovery of how a molecule regulates the robustness and duration of the immune response.
LONDON – New therapies for conditions such as cardiac hypertrophy and heart failure could be developed as a result of a better understanding of the minute regulation of gene transcription in heart muscle cells.
LONDON – An antibiotic compound originally described in 1953, but never developed, could hold the key to new treatments for multidrug-resistant strains of tuberculosis.
LONDON – An antibiotic compound originally described in 1953, but never developed, could hold the key to new treatments for multidrug-resistant strains of tuberculosis.
LONDON – Detailed analysis of genes associated with autoimmune diseases has identified three new regions where genetic variation plays a role in determining the risk of the autoimmune liver disease called primary biliary cirrhosis (PBC).
LONDON – Detailed analysis of genes associated with autoimmune diseases has identified three new regions where genetic variation plays a role in determining the risk of the autoimmune liver disease called primary biliary cirrhosis (PBC).
LONDON – A method of systematically screening a range of mutant mice for skeletal abnormalities has identified nine new genes that may be involved in human diseases such as osteoporosis and osteogenesis imperfecta (brittle bone disease).
LONDON – The discovery that some types of healthy brain cells release substances that can kill brain tumor cells by inducing the tumor cells to undergo cell death could point the way toward new therapies for brain tumors.
LONDON – The process by which tumors spread around the body involves a crucial molecular interaction between tumor cells in the bloodstream and the cells that line the blood vessels, a new study suggested.
